A carregar...
Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2
Cancer-related anemia is present in more than 60% of newly diagnosed cancer patients and is associated with substantial morbidity and high medical costs. Drugs that enhance erythropoiesis are urgently required to decrease transfusion rates and improve quality of life. Clinical studies have observed...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108889/ https://ncbi.nlm.nih.gov/pubmed/31895700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI133344 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|